Literature DB >> 19192471

A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method.

Abebaw Fekadu1, Sarah Wooderson, Catherine Donaldson, Kalypso Markopoulou, Brendan Masterson, Lucia Poon, Anthony J Cleare.   

Abstract

OBJECTIVE: Treatment resistance is a common clinical phenomenon in depression. However, current unitary models of staging fail to represent its complexity. We aimed to devise a model to stage treatment-resistant depression, taking into account the core factors contributing to treatment failure.
METHOD: We reviewed the literature to identify factors consistently associated with treatment resistance. We also analyzed data from a subgroup of patients discharged from a specialist inpatient unit for whom adequate data were obtainable.
RESULTS: We present a points-based staging model incorporating 3 factors: treatment, severity of illness, and duration of presenting episode. In this model, the rating of symptom severity ranges from subsyndromal depression (score 1) to severe syndromal depression with psychosis (score 5). Antidepressant treatment is rated on a 5-point subscale based on number of medications used, while duration of the presenting episode is rated on a 3-point subscale. The overall level of resistance estimated using this model varies from minimal resistance (score of 3) to severe resistance (score of 15). The rating system allows the overall severity of treatment resistance to be summarized either as a single numeric score or under a single descriptive category. It may also be possible to specify categories (mild, moderate, and severe) based on severity of resistance. Analysis of inpatient data indicates that the factors incorporated in the model and the model itself have some predictive validity.
CONCLUSION: This staging model has reasonable face and predictive validity and may have better utility in staging treatment resistance than currently available methods. Copyright 2009 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19192471     DOI: 10.4088/jcp.08m04309

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  57 in total

1.  Advances in the Management of Treatment-Resistant Depression.

Authors:  Paul E Holtzheimer
Journal:  Focus (Am Psychiatr Publ)       Date:  2010

2.  Quality of life across domains among individuals with treatment-resistant depression.

Authors:  Heidemarie Lex; Yarden Ginsburg; Adam F Sitzmann; Clara Grayhack; Daniel F Maixner; Brian J Mickey
Journal:  J Affect Disord       Date:  2018-09-19       Impact factor: 4.839

Review 3.  Annual Research Review: Defining and treating pediatric treatment-resistant depression.

Authors:  Jennifer B Dwyer; Argyris Stringaris; David A Brent; Michael H Bloch
Journal:  J Child Psychol Psychiatry       Date:  2020-02-04       Impact factor: 8.982

4.  Molecular serum signature of treatment resistant depression.

Authors:  Tillmann Ruland; Man K Chan; Pawel Stocki; Laura Grosse; Matthias Rothermundt; Jason D Cooper; Volker Arolt; Sabine Bahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-20       Impact factor: 4.530

5.  Deep brain stimulation for treatment-resistant depression.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Am J Psychiatry       Date:  2010-12       Impact factor: 18.112

Review 6.  Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.

Authors:  Noah S Philip; Linda L Carpenter; Audrey R Tyrka; Lawrence H Price
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

7.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

8.  Electroconvulsive Therapy Pulse Amplitude and Clinical Outcomes.

Authors:  Christopher C Abbott; Davin Quinn; Jeremy Miller; Enstin Ye; Sulaiman Iqbal; Megan Lloyd; Thomas R Jones; Joel Upston; Zhi De Deng; Erik Erhardt; Shawn M McClintock
Journal:  Am J Geriatr Psychiatry       Date:  2020-06-17       Impact factor: 4.105

9.  Unchanged Cognitive Performance and Concurrent Prefrontal Blood Oxygenation After Accelerated Intermittent Theta-Burst Stimulation in Depression: A Sham-Controlled Study.

Authors:  Wiebke Struckmann; Jonas Persson; Malin Gingnell; Wojciech Weigl; Caroline Wass; Robert Bodén
Journal:  Front Psychiatry       Date:  2021-06-30       Impact factor: 4.157

10.  Approaches to understanding and addressing treatment-resistant depression: a scoping review.

Authors:  Emily Jenkins; Elliot M Goldner
Journal:  Depress Res Treat       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.